InvestorsHub Logo
Followers 85
Posts 32745
Boards Moderated 86
Alias Born 03/22/2005

Re: neuroinv post# 1216

Tuesday, 09/19/2006 11:20:40 PM

Tuesday, September 19, 2006 11:20:40 PM

Post# of 50406
Neuro, With different head honchos running the two new CNS divisions of the FDA, with each having somewhat different approaches/agendas/egos, I wonder if there could be some regulatory confusion during the transition period? With Ampakines spanning the full spectrum of both Neurological and Psychiatric indications, won't there have to be some coordination between these two new CNS branches of the FDA when it comes to Ampakines?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RSPI News